Brian Joseph Cahill - 20 Dec 2021 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
Chief Financial Officer
Signature
/s/ Brian Cahill
Issuer symbol
EGRX
Transactions as of
20 Dec 2021
Net transactions value
-$25,881
Form type
4
Filing time
21 Dec 2021, 18:10:55 UTC
Next filing
07 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability $25,881 -467 -1.7% $55.42 27,099 20 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy withholding tax obligations.